| RS1689251604 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1689265228 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
6 conditions, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1689271621 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1689272728 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1689278062 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1689278461 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Early-infantile DEE |
| RS1689280236 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1689285717 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1689294239 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1689298277 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1689298888 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1689300152 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1689304332 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1689309551 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1689321394 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS16893332 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS1689333436 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1689339718 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1689344988 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 2, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1689347935 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1689350809 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1689352168 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1689357139 |
SATB2
|
Health Risk |
Pathogenic |
— |
| RS1689377026 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1689380193 |
ORC4
|
Health Risk |
Pathogenic |
— |
| RS1689381070 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1689412281 |
ORC4
|
Health Risk |
Pathogenic |
— |
| RS1689427568 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1689488709 |
SCN3A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1689552727 |
FASTKD2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation deficiency 44, Combined oxidative phosphorylation deficiency 44 |
| RS1689578912 |
ALS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS1689579412 |
RYR2
|
Health Risk |
Likely pathogenic |
— |
| RS1689580631 |
ALS2
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 2, juvenile |
| RS1689584119 |
ALS2
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 2, juvenile |
| RS1689596670 |
TTN
|
Health Risk |
Likely pathogenic |
Tibial muscular dystrophy, Tibial muscular dystrophy |
| RS1689669178 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1689679432 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1689679880 |
FANCL
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1689680658 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1689682880 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant epilepsy, Early-infantile DEE |
| RS1689684958 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1689685377 |
SCN1A
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS1689700102 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1689704657 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1689707865 |
SCN1A
|
Health Risk |
Pathogenic |
Microcephaly, Generalized epilepsy with febrile seizures plus |
| RS1689710741 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1689734633 |
SATB2
|
Health Risk |
Pathogenic |
— |
| RS1689734840 |
SATB2
|
Health Risk |
Pathogenic |
— |
| RS1689777278 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1689783166 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1689787372 |
TTN
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1689862418 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS1689931402 |
ALS2
|
Health Risk |
Pathogenic |
Juvenile amyotrophic lateral sclerosis, Infantile-onset ascending hereditary spastic paralysis |
| RS1689940049 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1689981394 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1689985819 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1689986058 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1689990205 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1689992185 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1690001575 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1690003122 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1690011364 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1690013843 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Severe myoclonic epilepsy in infancy |
| RS1690057369 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS1690065341 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1690066397 |
ICOS
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS1690111134 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1690115787 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, Dilated cardiomyopathy 1G |
| RS1690127143 |
RAB3GAP1
|
Health Risk |
Pathogenic |
18 conditions, 18 conditions |
| RS1690150292 |
FASTKD2
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation deficiency 44, Combined oxidative phosphorylation deficiency 44 |
| RS1690174710 |
BMPR2
|
Health Risk |
Likely pathogenic |
— |
| RS1690249361 |
TET3
|
Health Risk |
Likely pathogenic |
Beck-Fahrner syndrome, Beck-Fahrner syndrome |
| RS1690250283 |
TET3
|
Health Risk |
Likely pathogenic |
— |
| RS1690318147 |
SYT2
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 7, Congenital myasthenic syndrome 7 |
| RS1690331819 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1690335308 |
ALS2
|
Health Risk |
Likely pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS1690342079 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1690344942 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1690345764 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1690455297 |
SYT2
|
Health Risk |
Likely pathogenic |
— |
| RS16904774 |
TG
|
Health Risk |
Pathogenic/Likely pathogenic |
Iodotyrosyl coupling defect, Autoimmune thyroid disease |
| RS16904791 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS1690511212 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS1690515734 |
SYT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 7, Congenital myasthenic syndrome 7 |
| RS16905194 |
ZFAT
|
Health Risk |
risk factor |
Autoimmune thyroid disease, susceptibility to |
| RS1690523978 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS1690532210 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS1690571577 |
FANCL
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group L, Fanconi anemia |
| RS1690572580 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1690574155 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1690577824 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1690583220 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1690605753 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1690631284 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS1690636110 |
SYT2
|
Health Risk |
Likely pathogenic |
SYT2-related disorder, SYT2-related disorder |
| RS1690636140 |
ECEL1
|
Health Risk |
Pathogenic |
— |
| RS1690665406 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1690668690 |
ECEL1
|
Health Risk |
Likely pathogenic |
Distal arthrogryposis type 5D, Distal arthrogryposis type 5D |
| RS1690677282 |
GLE1
|
Health Risk |
Likely pathogenic |
— |
| RS1690729997 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |